[177Lu]Lu DOTA-ABM-5G / University of California - LARVOL DELTA

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer (clinicaltrials.gov) - P1 | N=30 | Recruiting | Sponsor: University of California, Davis | Trial completion date: Dec 2024 ➔ Jun 2026 | Trial primary completion date: Dec 2024 ➔ Jun 2026

Trial completion date • Trial primary completion date • Oncology • Pancreatic Adenocarcinoma • Pancreatic Cancer • Solid Tumor

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas (clinicaltrials.gov) - P1 | N=40 | Recruiting | Sponsor: University of California, Davis

Metastases • New P1 trial • Oncology